abt-199 and baricitinib

abt-199 has been researched along with baricitinib* in 1 studies

Reviews

1 review(s) available for abt-199 and baricitinib

ArticleYear
Repurposing BCL-2 and Jak 1/2 inhibitors: Cure and treatment of HIV-1 and other viral infections.
    Frontiers in immunology, 2022, Volume: 13

    Topics: COVID-19; Drug Repositioning; HIV Infections; HIV-1; Humans; Janus Kinases; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; STAT Transcription Factors; United States; Virus Latency

2022